Assessment of myocardial viability. Viability – Dysfunctional myocardium subtended by diseased coronary arteries – Limited or absent scarring – Potential.

Slides:



Advertisements
Similar presentations
PET AND PET/CT IN ISCHEMIC HEART DISEASE
Advertisements


CMR of Non-ischemic Dilated and Restrictive Cardiomyopathies
MYOCARDIAL STUNNING AND HIBERNATION
‘How I do’ CMR in DCM Dr Sanjay Prasad, Royal Brompton Hospital London, UK. For SCMR August 2006 This presentation is posted for members of scmr as an.
Friedrich, J Am Coll Cardiol 2008 Tissue characterization of acute myocardial infarction and myocarditis by CMR Matthias G. Friedrich Stephenson Cardiovascular.
Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction Robert O. Bonow, MD On behalf of the STICH Trial Investigators Myocardial Viability.
STRESS ECHO DEEPAK NANDAN. Stress echo is a family of examinations in which 2D echocardiographic monitoring is undertaken before, during & after cardiovascular.
Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.
Viability assessment and its role in Revascularization Review of evidence Dr. Nithin P G Dr Nithin P G.
SPECT imaging in cerebrovascular disease Measurement of regional cerebral blood flow (rCBF) Sensitive indicator of perfusion Diagnosis and prognosis of.
PHYSICS IN NUCLEAR MEDICINE: QUANTITAITVE SPECT AND CLINICAL APPLICATIONS Kathy Willowson Department of Nuclear Medicine, Royal North Shore Hospital University.
CURRENT STATUS OF STRESS TESTING JOHN HAMATY D.O..
Myocardial Ischemia, Injury, and Infarction
Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano aprile 2010 FEDERICA.
Ischemic Heart Diseases IHD
1. Review normal electrical flow through the heart. 2. Discuss normal coronary artery anatomy and associated leads reflecting ischemic changes. 3. Identify.
Diagnostic Stress Testing
Stress Testing Rajiv Perinbasekar. Stress Testing Electrocardiographic (ECG) stress testing Standard Echocardiographic (echo) stress testing Pharmacologic.
Stress testing Physiology: Sympathetic system activation increases: Heart rate Stroke volume Cardiac output Ventricular contractility Afterload (Vasoconstriction)
TRANSTHORACIC ECHOCARDIOGRAPHY & STRESS ECHO IHD MORTEZA ABDAR ESFAHANI MD. ADVANCED ECHOCARDIOLOGIST ( 3 D ) ASSOCIATE PROFESSOR OF ISFAHAN UNIVERSITY.
1 Dr. Zahoor Ali Shaikh. 2 CORONARY ARTERY DISEASE (CAD)  CAD is most common form of heart disease and causes premature death.  In UK, 1 in 3 men and.
Exercise Echocardiography Cardiac Issues 2011 Douglass A Morrison, MD, PhD.
NUCLEAR CARDIAC IMAGING
Case of the month Dr P Arumugam Consultant Nuclear Physician
John N. Hamaty D.O. Second year student module
Matthew Schumaecker, MD, FACC Assistant Professor of Medicine VTC School of Medicine.
Stress Testing and You: A Guide for the Interventionalist Matthew Schumaecker, MD Carilion Clinic April 7, 2014.
How I do CMR Myocardial Perfusion imaging SCMR Website 2006 Christopher Klassen MD, PHD University of Florida Health Science Center Dr. Norbert Wilke This.
Lesson 3 How to diagnose Coronary Artery Disease? Diagnostic.
Silent Ischemia STABLE CAD
Roles of Nuclear Cardiology, Cardiac Computed Tomography Cardiac Magnetic Resonance: Assessment of Patients with Suspected Coronary Artery Disease INT.
Angiographic Estimates of Myocardium at Risk During Acute Myocardial Infarction: a Validation Study Using Cardiac MRI José T. Ortiz, Sheridan N. Meyers,
Risk Stratification In Patients With Chronic Myocardial Ischemia.
Diabetes and Myocardial Ischaemia - Sensitivity of the diabetic heart to ischemic injury.
Nuclear Medicine in Cardiology Department of Nuclear Medicine Padjadjaran University – Dr. Hasan Sadikin Hospital A. Hussein S. Kartamihardja.
The transmural extent of late gadolinium enhancement detected with cardiovascular magnetic resonance in collateral dependent myocardium. Does a good collateral.
Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology Life Threatening Ventricular Arrhythmias: Current Role of.
Adult Echocardiography Lecture 10 Coronary Anatomy
JOURNAL REVIEW ANKUR KAMRA
Date of download: 5/31/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. Evaluation of the patient with known or suspected ischemic heart.
Acute Coronary Syndromes Chapter 12 Cardiovascular Disorders Medical Surgical Nursing II.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Acute Myocardial Infarction Early Viability Assessment.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Diagnostic Value of CMR in Patients With Biomarker-Positive.
J Am Coll Cardiol 2007;49:1715–21. Background Widespread use & recurrent improvements of the PCI method  significant reduction in early & late mortality.
Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: Contribution of Noninvasive Imaging to the Diagnosis.
Ischaemic heart disease. Coronary artery disease(CAD) is the leading cause of death worldwide. The rates of mortality and disability due to CAD are increasing.
Myocardial Perfusion Imaging
Radiopharmaceutical In Nuclear Cardiology
Myocardial stunning and hibernation
How We Do Dobutamine Stress Magnetic Resonance (DSMR)
Prognosis of Patients With LV Dysfunction and CAD
The NHLBI TIME Trial: Role of Microvascular Obstruction in 2-Year Clinical and MRI Follow-up Jay H. Traverse, MD Principal Investigator, TIME Study Minneapolis.
Cardiac Indices in Myocardial Perfusion Scan and Their Impact on the Patient's Prognosis
Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology Rubidium-82 PET imaging is feasible in a rat myocardial.
18th Annual Primary Care and Cardiovascular Symposium
Case No #1 Viability assessment
Myocardial Infarction and Ischemia
‘How I do’ CMR in DCM Dr Sanjay Prasad, Royal Brompton Hospital
How I do CMR Myocardial Perfusion imaging
Myocardial Perfusion Imaging Atomic Energy Medical Centre, JPMC.
Intensive Observation Unit Careggi University Hospital, Firenze Italy
by Thomas H. Marwick, and Markus Schwaiger Circ Cardiovasc Imaging
The Role of Stress Cardiac Magnetic Resonance in Women
Alexander Liu et al. JACC 2018;71:
Role of CT Coronary Angiogram in pre-renal transplant evaluation
Improved perfusion and contractile reserve after transmyocardial laser revascularization in a model of hibernating myocardium  G.Chad Hughes, MD, Alan.
NUCLEAR CARDIOLOGY- BASICS
Presentation transcript:

Assessment of myocardial viability

Viability – Dysfunctional myocardium subtended by diseased coronary arteries – Limited or absent scarring – Potential for functional recovery Prospective definition Reversible ischemic contractile dysfunction – Myocardial stunning – Myocardial hibernation

Myocardial stunning Heyndrickx et al 1978 Prolonged and fully reversible contractile dysfunction of the ischemic heart that persists after reperfusion Transient period of ischemia f/b reperfusion-depressed function at rest,preserved perfusion Affected area responsive to inotropes Time course not altered by use of inotropes- spontaneously resolve within a week Duration of stunning depends on the duration and severity of ischemia and the adequacy of arterial flow

Clinical relevance Exercise induced ischemia Acute cor.syndrome Angioplasty-balloon inflation Cardiopulmonary bypass

Mechanism Calcium hypothesis-decrease responsiveness to calcium Oxyradical hypothesis-ROS during reperfusion impairs calcium handling

Myocardial hibernation Diamond et al 1978 Persistent LV contractile dysfunction when myocardial perfusion is chronically reduced but sufficient to maintain viability of tissue Depressed function and perfusion at rest Progressively reversible after revascularisation Time to restoration- – Months to one year – Depend on duration and severity of flow reduction&ultrastructural changes

Mechanisms Smart heart hypothesis – Myocardial function &metabolism reduced to match a reduction in blood flow Repetitive stunning hypothesis – Repetitive episodes of ischemia reperfusion from supply demand mismatch leading to sustained depression of contractile function

Cellular mechanisms Apoptosis prominent during transition to hibernation-30%cell loss Compensatory regional myocyte hypertrophy-to maintain normal wall thickness Increase in interstitial connective tissue,myolysis,increased glycogen deposition,minimitochondria Cell survival programme-downregulation of glycogen synthase kinase,increase anti apoptotic proteins Downregulation of beta adrenergic adenylyl cyclase

Clinical assessment Heart failure and active angina – Directly angiography – Viability study may have a role in planning revascularisation strategy once coronary anatomy known Heart failure and no angina – Class 1 recommendation for assessment of viability in pts with CAD and LVD – Class 2a rec.for assessment of co-presence of CAD

STEMI – Class2a rec. for viability assessment 4 to 10 days after STEMI in hemodynamically&electrically stable pts.to define potential effect of revascularisation

Strong association b/w myocardial viability and improved survival after revascularization in pts with chronic CAD and LV dysfunction. – Allmann KC et al;JACC 2002 Pts with viability-revascularization a/w 79% reduction in mortality (16% vs. 3.2%) as compared to conserv.Rx Pts without viability-no significant difference in revasc. Vs medical therapy (7.7% vs. 6.2%)

In patients with ischemic cardiomyopathy 55% had viable myocardium by PET&27% had improved LVEF after revascularisation – Auerbach MA et al;circulation 1999

Techniques for assessment of viability Myocardial glucose utilisation-PET FDG Cell membrane integrity-SPECT Thallium Intact mitochondria-SPECT Tc Contractile reserve-dob.echo and dob.MRI Scar tissue-DEMRI,MSCT

Echocardiographic assessment LV end-diastolic wall thicknesses – Less than 6 mm-less likely to be viable

Dobutamine stress echo Low-dose dobutamine (5–10 μg/kg/min) – Increase contractility in viable myocardium High-dose dobutamine(upto 40 μg/kg/min) – Biphasic response –initial improvement F/B worsening – underperfused but viable tissue-most specific sign of improvement after revasc. – Uniphasic response-sustained improvement-myocardial damage with subsequent reperfusion-less predictive of improvement after revasc. – Deterioration of wall motion without initial improvement-severe ischemia – No change in wall motion-scar Sensitivity(84%),specificity(81%)for recovery of function

Strengths- – Higher specificity – Viability&ischemia assessed – MR can be detected – Good spatial resolution – Widely available – Lower cost – Predictive of clinical outcomes

Limitations – Poor window in 30% – Lower sensitivity – Viable regions with absent flow reserve will not show thickening – Reliance on visual assessment

Myocardial contrast echo Gas-filled microbubbles <7 μ as contrast agents Produces myocardial opacification and facilitates identification of LV borders Burst of high-intensity ultrasound-destroy microbubbles within the myocardium- replenishment observed over the next 10 to 15 cardiac cycles Viable if homogeneous contrast intensity Absence of contrast enhancement-nonviable myocardium

Sensitivity 89% and specificity of 51% Higher sensitivity,lower specificity compared to DSE

Strengths – Microcirculatory integrity – Extent of viability – Precise deleination – Viability assessed in total occlusion Limitation – Poor window – Scant clinical data

Myocardial strain rate imaging Determination of velocities in two segments of myocardium separated by a distance Strain rate is rate of change of velocity b/w these points Increased sensitivity from 73% to 83% compared to visual assessment

Echo based techniques Strengths – Safety, portability, low cost,widespread availability of equipment – Absence of radiation hazard Limitations – Operator dependent – Spatial resolution is relatively low – Diagnostic accuracy reduced in poor acoustic window

TMT Exercise induced ST elevation in infarct related area was associated with residual tissue viability – Margonoto et al ;JACC 1995 Sensitivity&specificity of reciprocal ST- segment depression a/w exercise-induced ST- segment elevation in prior Q wave infarct for detecting residual viability-84%&100% – Nakano A et al;JACC 1999

SPECT-Th-201 K+ analogue utilizes active cellular transport system-relies on intact cell Uptake depends on viability &regional perfusion Redistribution-gradual accumulation of tracer in hypoperfused areas,rapid washout from normally perfused areas Segments with tracer uptake >60%-viable Subendocardial scar tissue may be labelled as viable-lower specificity

Rest redistribution protocols- – Defects in initial images that improve in 4 hour image-viable myocardium – Additional 24 hr image if fixed defects in 4 hr image – S/L NTG prior to injection – Less sensitive-86%,specificity 47%

Rest redistribution thallium-defect in inferoseptal wall that redistributes

Stress redistribution protocol – Pharmac.or exercise stress – Th inj. &imaging f/b 4 hr image – Myocardium not perfused with rest or stress-scar – Defect on stress and improves on rest-ischemic &viable – 24 hr image for late redistribution

Stress redistribution reinjection protocols – Reinjection of Th201 and image repeated 24hr later – Viable myocadium-uptake of tracer on reinjection in segments with no uptake on stress – Scar –defect that persists – Sensitivity 90% specificity 54%

Tc99m labelled agents Rely on sarcolemmal integrity and mitochondrial function Short half life,higher doses,better image Redisribution less-less helpful in assessing viability Tc NOET-similar redistribution kinetics to Thallium Viability criterion is>50% tracer uptake in dysfunctional segments.

Ant Inf Lat Sep Apex  Base Ant Inf Apex Septum  Lateral Apex Sep Lat Inferior  Anterior Stress Rest Reversible Ischeamia, defect appears at stress and disappears during rest

Ant Inf Lat Sep Apex  Base Ant Inf Apex Septum  Lateral Apex Sep Lat Inferior  Anterior Stress Rest Fixed Scar, defect is seen in both stress and rest

Strengths – High sensitvity – Quantitative objective criteria – LVEF – FDG with special collimator – Predictive of outcomes

Limitations – Reduced spatial resolution &sensitivity compared to PET – Attenuation artefacts – Cannot differentiate endocardial viability – Less quantitative than PET

SPECT FDG High energy collimators to detect regional FDG uptake by SPECT camera. Concordance between 18FDG SPECT and 18FDG PET was 95% Sensitivity of 88% and specificity of 73% as compared to PET – Srinivasan G et al;circulation 1998 Increases sensitivity to detect viability compared to Thallium

PET Positron emitting isotopes releasing 2 photons at angle180,detected by camera by coincidence counting to give a higher resolution Perfusion tracers-N13 ammonia,Rb 82,O15 water Metabolic tracers- F18DG,C11acetate,C11 palmitate FDG taken up by viable cells,phoshorylated&trapped inside Poor uptake in diabetics

Interpretation Normal perfusion-viability Flow metabolism mismatch-reduced perfusion with intact metabolism-hibernating viable myocardium Flow metabolism match-impaired FDG uptake with reduced perfusion-scar Gold standard for assessment of viability

Perfusion metabolism mismatch-apex,anterior anterolateral wall

Strengths- – Perfusion &metabolism – More sensitive – No attenuation – Absolute blood flow can be measured – Predictive of outcomes

Limitations – Lower specificity to dob.echo&MRI – Cannot differentiate b/w endocardial and epicardial viability – High cost – Limited availability

Cardiac MRI Preserved wall thickness >5.5mm correlated with PET viability(sen.95%,spe.41%) – Baer FM et al;circulation 1995 Dobutamine cine MRI – Improved thickening>2mm by low dose dobutamine CMR(sen. 73%,spe.83%) – Higher accuracy than dobutamine echo – Monitoring difficult Delayed enhancement MRI(DEMRI) – Sen.95%,spe.45%

DEMRI using Gadolinium based agents (i.v.0.2 mmol/kg) Extracellular space Infarcted or scarred tissue-interstitial spaces larger-delayed wash in &delayed wash out Hyperenhanced area of myocardium on images taken 10 to 20 min after contrast Size and shape of infarct correlate with histology

Scarring begins at subendocardial surface and extends toward epicardium Transmural extent of infarct used to determine viability of each segment Likelihood of functional improvement inversely related to TEI 78%with no hyperenhancement improved,only 2% with >75% TEI improved – Kim RJ et al;NEJM 2000

Mean TEI 10%-Improved contractility after revasc. Mean TEI 41%-no improvement in contractility

Nuclear scintigraphy-% of viability in a given segment is assessed indirectly DEMRI-direct assessment of viability in a given segment

Indirect method show only 39% viability,direct method gives 70% viability-proven by revascularisation Mean transmural extent predicted irreversibility-41% by MRI,35% by histology DEMRI superior sensitivity&specificity to SPECT;similar sensitivity and superior specificity to PET

Strengths – Accurate assessment of extent of scar – Superior spatial resolution – Wall thickness correctly measired – Simultaneous assessment of perfusion,function and viability – Good imaging windows

Limitations – High cost – Limited availability – Longer time – Contra.with implanted ferromagnetic objects – Gadolinium contra.in CKD with GFR<30ml/min – Claustrophobia – Irregular rhythems – Breathholding required

MSCT Iodinated contrast agents accumulate in infarcted myocardium similar to DEMRI High spatial resolution-differentiation of transmural &subendocardial infarction possible Old infarctions have lower CT densities compared to recent infarcts Good agreement b/w DEMRI and late enhancement of MSCT

subendocardial hyperenhancement of the posterior wall

64-Slice Computed Tomography hyperenhancement of the inferior wall

Sensitivity&specificity -92%& 100% respectively to detect viability in acute myocardial infarction Presence of viable segments in an AMI identified when hyperenhancement is absent or involves <50% of the myocardial wall thickness Advantages – Shorter imaging time – widely available

Extent of viability Magnitude of improvement depends on quantitative extent of myocardial viability 25% of the LV should be viable by DSE&38% by nuclear imaging

Comparison of different techniques Baer FM,European heart journal 2000 – Higher accuracy for dob.TEE and dob.MRI for predicting improvement in LV function post revasc.

Comparison-DSE,MCE,SPECT shimoni et al;circulation2003

PET and SPECT have higher sensitivity &DSE has higher specificity for assessing viability – Robert Bonow;JACC 2002 Magnitude of improvement in outcome with revascularization did not differ whether assessed by PET,SPECT or DSE

DEMRI vs PET KLEIN et al;circulation 2002

DSE Vs nuclear imaging Sensitivity 90% for nuclear imaging,74% for DSE Specificity 57% for nuclear imaging,78% for DSE – Bax JJ et al;2002 Integration of both may be useful

Survival benefit